V
MRVI icon

Veritable’s Maravai LifeSciences MRVI Stock Holding History

Veritable’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,875
Closed -$303K – 881
2022
Q3 		$303K Sell
11,875
-3,858
-25% -$96.8K 0.01% 631
2022
Q2 		$447K Buy
15,733
+431
+3% +$13.7K 0.01% 564
2022
Q1 		$540K Sell
15,302
-220
-1% -$7.38K 0.01% 545
2021
Q4 		$650K Buy
15,522
+4,730
+44% +$192K 0.01% 492
2021
Q3 		$530K Buy
10,792
+5,204
+93% +$254K 0.01% 532
2021
Q2 		$233K Buy
+5,588
New +$217K ﹤0.01% 774

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Veritable's MRVI Position: Q4 2022 in Review

Veritable sold out of Maravai LifeSciences (MRVI) in Q4 2022, closing a stake of 11,875 shares — an estimated $303K sold.

Veritable first reported a position in MRVI in Q2 2021 and held it in 6 quarters. The position peaked at $650K in Q4 2021. 212 funds tracked by Wall St. Rank hold MRVI as of Q4 2022.

  • Veritable reported no remaining Maravai LifeSciences position as of Q4 2022 after selling out during the quarter.
  • Veritable sold 11,875 Maravai LifeSciences shares in Q4 2022, an estimated $303K.
  • Veritable first reported a position in Maravai LifeSciences in Q2 2021 and held it in 6 quarters.
  • Veritable's Maravai LifeSciences position peaked at $650K in Q4 2021.
  • 212 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2022.

Based on Veritable's 13F filing for Q4 2022, filed 14 Feb 2023.